KITE PHARMA INC's ticker is KITE and the CUSIP is 49803L109.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2017 | $76,000 | +181.5% | 421 | +58.9% | 0.00% | – |
Q2 2017 | $27,000 | -43.8% | 265 | -55.8% | 0.00% | – |
Q1 2017 | $48,000 | +500.0% | 600 | +200.0% | 0.00% | – |
Q4 2016 | $8,000 | -86.2% | 200 | -81.0% | 0.00% | – |
Q3 2016 | $58,000 | +100.0% | 1,050 | +82.3% | 0.00% | – |
Q2 2016 | $29,000 | +20.8% | 576 | +8.1% | 0.00% | – |
Q1 2016 | $24,000 | -41.5% | 533 | -21.3% | 0.00% | – |
Q4 2015 | $41,000 | +17.1% | 677 | +7.8% | 0.00% | – |
Q3 2015 | $35,000 | +34.6% | 628 | +45.0% | 0.00% | – |
Q2 2015 | $26,000 | -88.8% | 433 | -89.3% | 0.00% | – |
Q1 2015 | $232,000 | +2800.0% | 4,037 | +2846.7% | 0.00% | – |
Q4 2014 | $8,000 | – | 137 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Wildcat Capital Management, LLC | 2,410,034 | $433,348,000 | 77.71% |
COWEN INC. | 4,200,600 | $755,310,000 | 26.72% |
Tyrus Capital S.A.M. | 1,314,812 | $236,416,000 | 18.49% |
OMNI PARTNERS LLP | 661,711 | $118,982,000 | 15.19% |
FNY Partners Fund LP | 379,510 | $68,239,000 | 11.61% |
EQUITEC PROPRIETARY MARKETS, LLC | 240,100 | $43,172,000 | 10.15% |
EQUITEC PROPRIETARY MARKETS, LLC | 227,500 | $40,907,000 | 9.62% |
GARDNER LEWIS ASSET MANAGEMENT L P | 773,817 | $139,140,000 | 8.89% |
Quad Capital Management Advisors LLC | 192,537 | $34,620,000 | 7.10% |
Avoro Capital Advisors LLC | 496,983 | $89,363,000 | 6.93% |